See All Slides - tctmd.com

Slides

Presentation TCT 2012

Is This the Next Breakthrough Therapy? Technology and Data Overview

Presenter: Joachim Schofer

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Case Study(7)

Presenter: Christopher Granger

October 25, 2012

Presentation TCT 2012

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

Presenter: Javier Escaned

October 25, 2012

Presentation TCT 2012

Large Medical Device Company Perspectives

Presenter: Tony Blank

October 25, 2012

Presentation TCT 2012

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

Presenter: Yoshinobu Onuma

October 25, 2012

Presentation TCT 2012

FDA Perspectives

Presenter: Ashwani Sastry

October 25, 2012

Presentation TCT 2012

Post-EVAR Follow-up and Imaging Surveillance: Current and Future Trends

Presenter: Robert Lookstein

October 25, 2012

Presentation TCT 2012

Can Any IVUS/OCT Parameters Replace FFR?

Presenter: Bon-Kwon Koo

October 25, 2012

Presentation TCT 2012

Has Progress Been Made with Post-MI VSD Closure?

Presenter: Eustaquio Maria Onorato

October 25, 2012

Advertisement

Slides

Is This the Next Breakthrough Therapy? Technology and Data Overview

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Case Study(7)

OCT/FFR Correlation: Do the Combined Technologies Have a Role in Assessing Lesion Severity?

Large Medical Device Company Perspectives

BVS Follow-up Using Multiple Imaging Modalities: Research Implications vs. Clinical Utility

FDA Perspectives

Post-EVAR Follow-up and Imaging Surveillance: Current and Future Trends

Can Any IVUS/OCT Parameters Replace FFR?

Has Progress Been Made with Post-MI VSD Closure?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content